- Home
- ONB vs ROIV Comparison
ONB vs ROIV Comparison
Compare ONB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- ROIV
- Stock Information
- Founded
- ONB 1834
- ROIV 2014
- Country
- ONB United States
- ROIV United Kingdom
- Employees
- ONB N/A
- ROIV N/A
- Industry
- ONB Major Banks
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- ONB Finance
- ROIV Health Care
- Exchange
- ONB Nasdaq
- ROIV Nasdaq
- Market Cap
- ONB 8.1B
- ROIV 8.6B
- IPO Year
- ONB N/A
- ROIV N/A
- Fundamental
- Price
- ONB $21.79
- ROIV $14.18
- Analyst Decision
- ONB Buy
- ROIV Strong Buy
- Analyst Count
- ONB 10
- ROIV 4
- Target Price
- ONB $26.60
- ROIV $15.50
- AVG Volume (30 Days)
- ONB 2.8M
- ROIV 6.8M
- Earning Date
- ONB 10-21-2025
- ROIV 11-11-2025
- Dividend Yield
- ONB 2.57%
- ROIV N/A
- EPS Growth
- ONB N/A
- ROIV N/A
- EPS
- ONB 1.67
- ROIV N/A
- Revenue
- ONB $1,893,728,000.00
- ROIV $23,233,000.00
- Revenue This Year
- ONB $44.99
- ROIV N/A
- Revenue Next Year
- ONB $15.31
- ROIV $281.14
- P/E Ratio
- ONB $13.05
- ROIV N/A
- Revenue Growth
- ONB 9.52
- ROIV N/A
- 52 Week Low
- ONB $16.83
- ROIV $8.73
- 52 Week High
- ONB $24.49
- ROIV $14.48
- Technical
- Relative Strength Index (RSI)
- ONB 44.08
- ROIV 75.19
- Support Level
- ONB $22.29
- ROIV $13.81
- Resistance Level
- ONB $23.32
- ROIV $14.48
- Average True Range (ATR)
- ONB 0.55
- ROIV 0.43
- MACD
- ONB -0.11
- ROIV 0.17
- Stochastic Oscillator
- ONB 11.05
- ROIV 88.76
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.